892 related articles for article (PubMed ID: 29882812)
1. Pharmacological Targeting of Cell Cycle, Apoptotic and Cell Adhesion Signaling Pathways Implicated in Chemoresistance of Cancer Cells.
Alimbetov D; Askarova S; Umbayev B; Davis T; Kipling D
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29882812
[TBL] [Abstract][Full Text] [Related]
2. TAK-ing aim at chemoresistance: The emerging role of MAP3K7 as a target for cancer therapy.
Santoro R; Carbone C; Piro G; Chiao PJ; Melisi D
Drug Resist Updat; 2017 Nov; 33-35():36-42. PubMed ID: 29145973
[TBL] [Abstract][Full Text] [Related]
3. Inside the biochemical pathways of thymidylate synthase perturbed by anticancer drugs: Novel strategies to overcome cancer chemoresistance.
Taddia L; D'Arca D; Ferrari S; Marraccini C; Severi L; Ponterini G; Assaraf YG; Marverti G; Costi MP
Drug Resist Updat; 2015 Nov; 23():20-54. PubMed ID: 26690339
[TBL] [Abstract][Full Text] [Related]
4. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
5. Mitochondria and cancer chemoresistance.
Guerra F; Arbini AA; Moro L
Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):686-699. PubMed ID: 28161329
[TBL] [Abstract][Full Text] [Related]
6. Adhesion dependent signalling in the tumour microenvironment: the future of drug targetting.
Bewick MA; Lafrenie RM
Curr Pharm Des; 2006; 12(22):2833-48. PubMed ID: 16918414
[TBL] [Abstract][Full Text] [Related]
7. Nicotinic acetylcholine receptors in chemotherapeutic drugs resistance: An emerging targeting candidate.
Afrashteh Nour M; Hajiasgharzadeh K; Kheradmand F; Asadzadeh Z; Bolandi N; Baradaran B
Life Sci; 2021 Aug; 278():119557. PubMed ID: 33930371
[TBL] [Abstract][Full Text] [Related]
8. Microenvironment acidity as a major determinant of tumor chemoresistance: Proton pump inhibitors (PPIs) as a novel therapeutic approach.
Taylor S; Spugnini EP; Assaraf YG; Azzarito T; Rauch C; Fais S
Drug Resist Updat; 2015 Nov; 23():69-78. PubMed ID: 26341193
[TBL] [Abstract][Full Text] [Related]
9. Cancer therapy: targeting cell cycle regulators.
Johansson M; Persson JL
Anticancer Agents Med Chem; 2008 Oct; 8(7):723-31. PubMed ID: 18855574
[TBL] [Abstract][Full Text] [Related]
10. [Integrins, cell response to anti-tumor agents and chemoresistance].
Maubant S; Staedel C; Gauduchon P
Bull Cancer; 2002 Nov; 89(11):923-34. PubMed ID: 12495880
[TBL] [Abstract][Full Text] [Related]
11. Cancer therapeutics: Targeting the apoptotic pathway.
Khan KH; Blanco-Codesido M; Molife LR
Crit Rev Oncol Hematol; 2014 Jun; 90(3):200-19. PubMed ID: 24507955
[TBL] [Abstract][Full Text] [Related]
12. Apoptosis-modulating drugs for improved cancer therapy.
Ocker M; Höpfner M
Eur Surg Res; 2012; 48(3):111-20. PubMed ID: 22538523
[TBL] [Abstract][Full Text] [Related]
13. Changes in the apoptotic and survival signaling in cancer cells and their potential therapeutic implications.
Kabore AF; Johnston JB; Gibson SB
Curr Cancer Drug Targets; 2004 Mar; 4(2):147-63. PubMed ID: 15032666
[TBL] [Abstract][Full Text] [Related]
14. Physiological modulation approaches to improve cancer chemotherapy : a review.
Kumar R; Kaur M; Silakari O
Anticancer Agents Med Chem; 2014 Jun; 14(5):713-49. PubMed ID: 24117110
[TBL] [Abstract][Full Text] [Related]
15. Rho GTPases: Promising candidates for overcoming chemotherapeutic resistance.
Zheng CW; Zeng RJ; Xu LY; Li EM
Cancer Lett; 2020 Apr; 475():65-78. PubMed ID: 31981606
[TBL] [Abstract][Full Text] [Related]
16. Tissue transglutaminase-mediated chemoresistance in cancer cells.
Verma A; Mehta K
Drug Resist Updat; 2007; 10(4-5):144-51. PubMed ID: 17662645
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic targeting of death pathways in cancer: mechanisms for activating cell death in cancer cells.
Tan TT; White E
Adv Exp Med Biol; 2008; 615():81-104. PubMed ID: 18437892
[TBL] [Abstract][Full Text] [Related]
18. Mutations of p53 and KRAS activate NF-κB to promote chemoresistance and tumorigenesis via dysregulation of cell cycle and suppression of apoptosis in lung cancer cells.
Yang L; Zhou Y; Li Y; Zhou J; Wu Y; Cui Y; Yang G; Hong Y
Cancer Lett; 2015 Feb; 357(2):520-6. PubMed ID: 25499080
[TBL] [Abstract][Full Text] [Related]
19. Hypoxia-mediated drug resistance: novel insights on the functional interaction of HIFs and cell death pathways.
Rohwer N; Cramer T
Drug Resist Updat; 2011 Jun; 14(3):191-201. PubMed ID: 21466972
[TBL] [Abstract][Full Text] [Related]
20. Dexamethasone enhances cell resistance to chemotherapy by increasing adhesion to extracellular matrix in human ovarian cancer cells.
Chen YX; Wang Y; Fu CC; Diao F; Song LN; Li ZB; Yang R; Lu J
Endocr Relat Cancer; 2010 Mar; 17(1):39-50. PubMed ID: 19776289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
